Jul. 28 at 9:22 PM
$CANF Well, its hard to tell exactly why this fell to this level (of course 5% -30 yr t-bill and
$15 million offering). But I was a key exec for Amgen for 15 years of my career, and funding the research along the way is part of the deal. But I know I couldn't buy CANF for under
$1 for the longest time. I actually was the youngest person to ever present at the National Cancer Institute in 1977 at age 19, and my presentation was on the mechanism of action of this biological engine (cAMP/cGMP) as a possible universal cure for cancers. This is Canf's drug now. So I presented the theory, but the tools were not yet invented to make it happen. So I am a believer..now comes the execution.
DR Kellerman
